33045804|t|Development of donepezil-induced hypokalemia following treatment of cognitive impairment.
33045804|a|Donepezil is a cholinesterase inhibitor used extensively to treat Alzheimer disease. The increased cholinergic activity is associated with adverse effects, therefore gastrointestinal symptoms, including nausea, vomiting, and diarrhea, are common. Hypokalemia is a rare adverse event that occurs in less than 1% of donepezil-treated patients. Although hypokalemia of mild and moderate grade does not present serious signs and symptoms, severe hypokalemia often results in prolonged hospitalization and mortality. Herein, we report a case of hypokalemia developed after the initiation of donepezil therapy for cognitive impairment.
33045804	15	24	donepezil	Chemical	MESH:D000077265
33045804	33	44	hypokalemia	Disease	MESH:D007008
33045804	68	88	cognitive impairment	Disease	MESH:D003072
33045804	90	99	Donepezil	Chemical	MESH:D000077265
33045804	105	119	cholinesterase	Gene	590
33045804	156	173	Alzheimer disease	Disease	MESH:D000544
33045804	256	281	gastrointestinal symptoms	Disease	MESH:D012817
33045804	293	309	nausea, vomiting	Disease	MESH:D020250
33045804	315	323	diarrhea	Disease	MESH:D003967
33045804	337	348	Hypokalemia	Disease	MESH:D007008
33045804	404	413	donepezil	Chemical	MESH:D000077265
33045804	422	430	patients	Species	9606
33045804	441	452	hypokalemia	Disease	MESH:D007008
33045804	532	543	hypokalemia	Disease	MESH:D007008
33045804	630	641	hypokalemia	Disease	MESH:D007008
33045804	676	685	donepezil	Chemical	MESH:D000077265
33045804	698	718	cognitive impairment	Disease	MESH:D003072
33045804	Positive_Correlation	MESH:D000077265	MESH:D012817
33045804	Negative_Correlation	MESH:D000077265	590
33045804	Negative_Correlation	MESH:D000077265	MESH:D003072
33045804	Positive_Correlation	MESH:D000077265	MESH:D003967
33045804	Positive_Correlation	MESH:D000077265	MESH:D020250
33045804	Negative_Correlation	MESH:D000077265	MESH:D000544
33045804	Positive_Correlation	MESH:D000077265	MESH:D007008

